1 completed, 1 recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 2 | Completed 1, Recruiting 1 |
Follow PFT: new trials by email Literature Review of PFT trials Research Report on PFT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| E7 TCR T Cells for Human Papillomavirus-Associated Cancers E7 TCR cells, Aldesleukin, Fludarabine - Papillomavirus Infections, Cervical Intraepithelial Neoplasia | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 224 | 2017-01-27 | 2026-03-09 |
| Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis albuterol inhaler, albuterol nebulizer, PFT - Lymphangioleiomyomatosis | Phase 1 / Phase 2 | Recruiting | National Heart, Lung, and Blood Institute (NHLBI) | 100 | 2013-06-10 | 2026-10-29 |
Carcinoma in Situ (1) · Lymphangioleiomyomatosis (1) · Papillomavirus Infections (1) · Uterine Cervical Dysplasia (1) · Vulvar Diseases (1) · Vulvar Neoplasms (1)
National Cancer Institute (NCI) (1) · National Heart, Lung, and Blood Institute (NHLBI) (1)
United States (2)
Joel Moss, M.D. (1) · Scott M Norberg, D.O. (1)